Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping

Journal of Neuro-Oncology

Volumn 52, Issue 2, 2001, Pages 119-128

  Krex, D ^a   Mohr, B ^a   Hauses, M ^a   Ehninger, G ^a   Schackert, H K ^b   Schackert, G ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Glioma pathogenesis; Glioma derived cell line; Neuroglioma; Spectral karyotyping

Indexed keywords

HYBRID PROTEIN; MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CHROMOSOME 13Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME IDENTIFICATION; CHROMOSOME INSERTION; CHROMOSOME MOSAICISM; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOCUS; GENE LOSS; GENE PROBE; GENETIC ANALYSIS; GLIOMA CELL; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; INTERPHASE; KARYOTYPING; MALE; MALIGNANT TRANSFORMATION; METAPHASE CHROMOSOME; MOSAICISM; QUANTITATIVE ASSAY; SPECTROMETRY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE DUPLICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034915238     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010680920087     Document Type: Article

References (41)

1. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: An analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991
2. A cytogenetic study of 53 human gliomas
3. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and non-random chromosomal gains and losses
4. Molecular pathways in the formation of gliomas
5. PTEN mutations in gliomas and glioneuronal tumors
6. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance
7. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors
8. Propagation of human tumors in antithymocyte serum-treated mice
9. Multicolor spectral karyotyping of human chromosomes
10. The coloring of cytogenetics
11. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas
12. Contrary effect of lactic acid on expression of neuron-specific enolase and glial fibrillary acidic protein in human glioma cells
13. Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme
14. Immunohistochemistry of synapsin I and synaptophysin in human nervous system and neuroendocrine tumors. Applications in diagnostic neuro-oncology
15. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification
16. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas
17. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours
18. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancer
19. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region
20. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells
21. Mutational analysis of the PTEN gene in gliomas: Molecular and pathological correlations
22. Tumor suppressor gene alterations in malignant gliomas: Histopathological associations and prognostic evaluation
23. The retinoblastoma gene is involved in malignant progression of astrocytomas
24. Molecular analysis of genomic abnormalities in human gliomas
25. p15(INK4B) is a potential effector of TGF-beta-induced cell cycle arrest
26. A cell cycle regulator potentially involved in genesis of many tumor types
27. Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis
28. Chromosomal composition of four permanent cultured cell lines derived from human gliomas
29. Gliomas in families: Chromosomal analysis by comparative genomic hybridization
30. Evidence of focal genetic micro-heterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells
31. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11
32. Molecular cytogenetics localizes two new breakpoints on 11q23.3 and 21q11.2 in myelodysplastic syndrome with t(11;21) translocation
33. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
34. Molecular changes during the genesis of human gliomas
35. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation
36. Cytogenetics of malignant gliomas: I. The autosomes with reference to rearrangements
37. Cytogenetic follow-up from direct preparation to advanced in vitro passages of a human malignant glioma
38. Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro
39. Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas
40. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping